These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 1958552

  • 1. The cortisol-cortisone shuttle and hypertension.
    Stewart PM, Edwards CR.
    J Steroid Biochem Mol Biol; 1991; 40(4-6):501-9. PubMed ID: 1958552
    [Abstract] [Full Text] [Related]

  • 2. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
    Stewart PM, Whorwood CB, Walker BR.
    Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
    [Abstract] [Full Text] [Related]

  • 3. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM, Corrie JE, Shackleton CH, Edwards CR.
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [Abstract] [Full Text] [Related]

  • 4. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
    Walker BR, Stewart PM, Shackleton CH, Padfield PL, Edwards CR.
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136
    [Abstract] [Full Text] [Related]

  • 5. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
    Edwards CR, Stewart PM.
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
    [Abstract] [Full Text] [Related]

  • 6. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.
    Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CR.
    Clin Sci (Lond); 1990 Jan; 78(1):49-54. PubMed ID: 2153495
    [Abstract] [Full Text] [Related]

  • 7. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
    Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR.
    Lancet; 1987 Oct 10; 2(8563):821-4. PubMed ID: 2889032
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A non-isotopic method for estimating 11 beta hydroxysteroid dehydrogenase activity in vivo.
    Bayly GR, Bartlett WA, Jones AF.
    Ann Clin Biochem; 1997 Sep 10; 34 ( Pt 5)():521-6. PubMed ID: 9293306
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA.
    Rev Med Chil; 2000 Jan 10; 128(1):17-26. PubMed ID: 10883518
    [Abstract] [Full Text] [Related]

  • 16. Lessons from licorice.
    Edwards CR.
    N Engl J Med; 1991 Oct 24; 325(17):1242-3. PubMed ID: 1656256
    [No Abstract] [Full Text] [Related]

  • 17. Apparent mineralocorticoid excess type II.
    Mantero F, Tedde R, Opocher G, Dessi Fulgheri P, Arnaldi G, Ulick S.
    Steroids; 1994 Feb 24; 59(2):80-3. PubMed ID: 8191552
    [Abstract] [Full Text] [Related]

  • 18. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P, Lovati E, Frey FJ.
    J Hypertens; 2000 Mar 24; 18(3):241-8. PubMed ID: 10726708
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.